Search clinical trials for: [18F]MNI-1054

Total 9095 results

Invicro

Completed

Assessment of [18F]MNI-1054 as a Marker for LSD1

Healthy Volunteers (HV)

United States
Invicro

Completed

Assessment of the Biodistribution and Safety of [18F]MNI-1054

Healthy Volunteers

United States
Takeda

Terminated

A Study With [18F]MNI-1054 to Determine Lysine -Specific Demethylase 1A (LSD1) Brain Enzyme Occupancy of TAK-418 After Single-Dose Oral Administration in Healthy Participants

Healthy Volunteers

United States
Molecular NeuroImaging
Life Molecular Imaging SA

Completed

Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies

Alzheimer's Disease (AD) | Progressive Supranuclear Palsy (PSP) | Frontal Temporal Dementia (FTD) | Cortical Basal Syndrome (CBS)

United States
Genentech, Inc.

Completed

Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Alzheimer's Disease

United States
Invicro

Completed

Phase 1 Test-retest Evaluation of [18F]MNI-958 PET

Alzheimer Disease | Healthy Volunteers | Progressive Supranuclear Palsy

United States
Molecular NeuroImaging

Completed

Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

Alzheimer Disease | Healthy Volunteers | Progressive Supranuclear Palsy

United States
Molecular NeuroImaging

Completed

Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

Alzheimer Disease | Healthy Volunteers | Progressive Supranuclear Palsy

United States
Eli Lilly and Company

Completed

A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants

Healthy

United States
Eli Lilly and Company

Completed

A Study of the Effects of LY3372689 on the Brain in Healthy Participants

Healthy

United States
Chang Gung Memorial Hospital

Recruiting

Image Characteristic and Longitudinal Follow up of 18F-PMPBB3 (APN-1607) PET for Progressive Supranuclear Palsy

Progressive Supranuclear Palsy

Taiwan
Invicro

Completed

Assessment of the Biodistribution and Safety of [18F]MNI-958 in Healthy Subjects

Healthy Volunteers

United States
Avid Radiopharmaceuticals

Completed

18F-LY3950321-01 Biodistribution and Safety Study

Radiation Exposure | Diagnostic Agent Adverse Reaction

United States
Invicro

Completed

Evaluation of [18F]MNI-1126 as an Imaging Marker for Synaptic Density Loss

Parkinson Disease | Alzheimer Disease | Healthy Volunteers

United States
Institute for Neurodegenerative Disorders
Molecular NeuroImaging

Completed

Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558 (MNI-558)

Alzheimer Disease

United States
Invicro

Completed

Phase 1 Evaluation of [18F]MK-6240 PET as an Imaging Marker for Tau Protein

Alzheimer Disease | Healthy Volunteers

United States
CHDI Foundation, Inc.

Completed

Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers (LONGPDE10)

Huntington's Disease

Sweden, Denmark, Netherlands, Norway
Mayo Clinic
Blue Earth Diagnostics, Inc

Recruiting

18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain

Metastatic Intracranial Malignant Neoplasm | Recurrent Intracranial Neoplasm

United States
Molecular NeuroImaging

Completed

Assessment of the Biodistribution and Safety of [18F]MNI-968 in Healthy Subjects

Healthy Volunteers

United States
Molecular NeuroImaging
Institute for Neurodegenerative Disorders

Completed

Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects

Alzheimer's Disease (AD) | Tauopathies | Parkinson's Disease (PD) | Progressive Supranuclear Palsy (PSP) | Chronic Traumatic Encephalopathy (CTE) | Frontal Temporal Dementia (FTD) | Pick's Disease

United States
Martin Dichgans
University Hospital Muenster; Universitätsklinikum Hamburg-Eppendorf

Recruiting

Inflammatory faCtors AfteR acUte Ischemic Stroke (ICARUS)

Ischemic Stroke

Germany
Invicro

Completed

D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562

Healthy Male Volunteers

United States
University of Alabama at Birmingham

Completed

Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI

Prostate Cancer

United States
Merck Sharp & Dohme LLC

Completed

[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)

Alzheimer's Disease | Amnestic Mild Cognitive Impairment
Assistance Publique - Hôpitaux de Paris

Recruiting

Remyelination in Multiple Sclerosis: a PET-MR Longitudinal Study Investigating Individual Profiles of Myelin Repair and the Contribution of Neuroinflammation (SMARTinMS)

Multiple Sclerosis | Inflammatory Disease

France
Molecular NeuroImaging

Completed

Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects

Healthy Volunteers

United States
Massachusetts General Hospital
Cedars-Sinai Medical Center; ALS Association; The Methodist Hospital Research...

Completed

Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis (TRACK-ALS)

Amyotrophic Lateral Sclerosis (ALS)

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Terminated

Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy

Prostate Cancer

United States
Istituto Clinico Humanitas
Mediolanum Cardio Research

Not yet recruiting

Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.

Glioblastoma

Italy
University of North Carolina, Chapel Hill
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI

Endometriosis

United States
British Columbia Cancer Agency

No longer available

18F-FDOPA PET in Neuroendocrine Tumours

Thyroid Cancer, Medullary | Neuroblastoma | Pheochromocytoma | Carcinoid Tumor | Paraganglioma | Insulinoma

Canada
Avid Radiopharmaceuticals
Eli Lilly and Company

Completed

A Study of Florbetapir (18F) in Japanese Healthy Volunteers

Alzheimer's Disease

Japan
Avid Radiopharmaceuticals

Completed

The Feasibility of Florbetapir Quantitation in Europe

Alzheimer's Disease

Netherlands
Avid Radiopharmaceuticals
Eli Lilly and Company

Completed

A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

Mild Cognitive Impairment | Alzheimer's Disease

Japan
Frederick Daniel Grant
Dana-Farber Cancer Institute

Completed

FLT-PET Imaging of Brain Tumors in Children

Brain Neoplasms

United States
Avid Radiopharmaceuticals

Withdrawn

Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians

Alzheimer's Disease

Japan
Markus Weber
University Hospital Inselspital, Berne; ETH Zurich

Not yet recruiting

Investigation of Cannabinoid 2-receptor Expression in the Brain and Spine of ALS-patients Compared to Healthy Controls With PET (18F-RoSMALS) (18F-RoSMALS)

Amyotrophic Lateral Sclerosis

Switzerland
Children's Hospital of Philadelphia
Blue Earth Diagnostics, Inc; Dragon Master Foundation

Recruiting

18F-Fluciclovine PET-MRI in High-grade Glioma

Glioma | High Grade Glioma | Glioma, Malignant | Diffuse Glioma | Glioma Intracranial

United States
University of Alabama at Birmingham

Recruiting

Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI

HER2-positive Breast Cancer

United States
Hospices Civils de Lyon

Completed

(18)F-FDG PET Database of Adult Healthy Individuals (BDD-FDG)

Healthy

France
University of Alabama at Birmingham

Active, not recruiting

Neuroinflammation After Myocardial Infarction - Imaging Substudy

Myocardial Infarction

United States
Lawson Health Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer (IGPC-3)

Prostate Cancer

Canada
Janssen Research & Development, LLC

Completed

Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Alzheimer Disease

United States
Takeda

Completed

A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935

Epilepsy, Molecular Mechanisms of Pharmalogical Action, Protective Agents

United States
Avid Radiopharmaceuticals
Eli Lilly and Company

Completed

Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline

Alzheimer's Disease

France, Italy, United States
Chang Gung Memorial Hospital

Unknown

Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET Examination (PMPBB3/AV45)

Alzheimer's Disease

Taiwan
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET) (INFLANET)

Multiple Sclerosis

France
University of Wisconsin, Madison
National Institute on Aging (NIA)

Recruiting

Comparison of Microglial Activation in Severe Asthma and Healthy Controls (MAIA-SC)

Asthma

United States
National Cancer Centre, Singapore

Recruiting

A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer

Cervix Cancer | Image, Body

Singapore
Memorial Sloan Kettering Cancer Center

Terminated

Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer

Cervical Cancer

United States

Search clinical trials for: [18F]MNI-1054

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations